Twenty patients who had experienced heartburn and/or acid regurgitation for at least 3 days during a 7 day run-in period , without endoscopic mucosal breaks , were randomized in a double blind crossover study to receive four daily doses of a fixed oral combination of HA+CS and placebo for 14 days .